eISSN: 2084-9885
ISSN: 1896-6764
Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
4/2012
vol. 7
 
Share:
Share:
more
 
 
abstract:

Review article
Efficacy of different interferon beta preparations in multiple sclerosis. Review of open label comparative studies

Tomasz Berkowicz

Neuropsychiatria i Neuropsychologia 2012; 7, 4: 175–180
Online publish date: 2013/01/31
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Beta interferon is the first-line immunomodulatory agent approved for remitting-relapsing multiple sclerosis. Several preparations of interferon beta 1b and interferon beta 1a are available for treatment. The author reviews the publications on 13 open-label studies comparing the efficacy of interferon beta preparations. Based on current clinical data we can conclude that differences in efficacy between various preparations of beta interferon are subtle and often undetectable. Therefore, the individual patient response to particular treatment, tolerability, administration route, compliance and costs of the treatment should determine the therapeutic decision.
keywords:

interferon β, efficacy, multiple sclerosis

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe